Spravato® (esketamine) is an innovative, FDA-approved nasal spray used to treat adults with treatment-resistant depression and depressive symptoms with suicidal thoughts or actions. Unlike traditional antidepressants that can take weeks to work, Spravato® acts on a different brain pathway, helping to rapidly improve mood and reduce suicidal ideation in some patients. Treatment is administered in-office under medical supervision to ensure comfort and safety.